Skip to main content

Table 1 Patient characteristics

From: Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma: a double-blind placebo-controlled trial

 

Total

Adult

Children

Placebo

sc-LCPUFA

Subjects

[n]

64

34

30

32

32

Female/Male

[n]

35/29

22/12

13/17

16/16

19/13

Age

[yrs]

19.0 ± 5.5

23.5 ± 3.0

13.8 ± 2.2

18.4 ± 5.0

19.5 ± 6.0

Weight

[kg]

61.0 ± 14.0

67.6 ± 12.4

53.6 ± 11.9

60.1 ± 13.6

62.0 ± 14.6

Height

[m]

1.7 ± 0.1

1.7 ± 0.1

1.6 ± 0.1

1.7 ± 0.1

1.7 ± 0.1

FVC

[% pred]

96.6

(70.2–140.1)

94.0

(70.2–117.3)

98.8

(77.7–140.1)

96.7

(70.2–114.7)

96.3

(82.6–140.1)

FEV1

[% pred]

94.9

(64.4–118.4)

91.8

(64.4–115.2)

97.3

(69.6–118.4)

95.3

(64.4–111.0)

92.9

(72.6–118.4)

eNO

[ppb]

27.5

(5.0–197.0)

27.5

(5.0–197.0)

28.5

(7.0–88.0)

31.5

(6.0–96.0)

20.5

(5.0–197.0)

ACQ

 

0.7

(0.0–2.9)

0.7

(0.0–2.9)

0.8

(0.0–2.0)

0.9

(0.0–2.9)

0.7

(0.0–2.0)

  1. Normally distributed data mean ± SD; not normally distributed data and % values median and min/max; SD Standard deviation, n Number, yrs Years, m Meter, kg Kilogram, % pred % predicted, ppb Parts per billion